DKCM
STJ

Davidson Kempner Capital Management’s St Jude Medical STJ Stock Holding History

Davidson Kempner Capital Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,750,204
Closed -$301M – 224
2016
Q4 		$301M Buy
3,750,204
+1,586,599
+73% +$126M 6.09% 3
2016
Q3 		$173M Buy
2,163,605
+319,945
+17% +$25.8M 4.24% 5
2016
Q2 		$144M Buy
+1,843,660
New +$131M 3.37% 7
2013
Q4 		– Sell
-27,000
Closed -$1.45M – 176
2013
Q3 		$1.45M Buy
+27,000
New +$1.39M 0.05% 118

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Davidson Kempner Capital Management's STJ Position: Q1 2017 in Review

Davidson Kempner Capital Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 3,750,204 shares — an estimated $301M sold.

Davidson Kempner Capital Management first reported a position in STJ in Q3 2013 and held it in 4 quarters. The position peaked at $301M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Davidson Kempner Capital Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 3,750,204 St Jude Medical shares in Q1 2017, an estimated $301M.
  • Davidson Kempner Capital Management first reported a position in St Jude Medical in Q3 2013 and held it in 4 quarters.
  • Davidson Kempner Capital Management's St Jude Medical position peaked at $301M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Davidson Kempner Capital Management's 13F filing for Q1 2017, filed 15 May 2017.